Hikma Pharmaceuticals PLC (LON:HIK)

Hikma Pharmaceuticals Revenue

Hikma Pharmaceuticals had revenue of $1.73B USD in the half year ending June 30, 2026, with 10.13% growth. This brings the company's revenue in the last twelve months to $3.42B, up 6.31% year-over-year. In the year 2025, Hikma Pharmaceuticals had annual revenue of $3.35B with 7.10% growth.

• Revenue (ttm): $3.42B
• Revenue Growth: +6.31%
• P/S Ratio: 1.34
• Revenue / Employee: $359.89K
• Employees: 9,500
• Market Cap: 3.44B GBP

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.35B	222.00M	7.10%
Dec 31, 2024	3.13B	252.00M	8.77%
Dec 31, 2023	2.88B	358.00M	14.22%
Dec 31, 2022	2.52B	-36.00M	-1.41%
Dec 31, 2021	2.55B	212.00M	9.06%
Dec 31, 2020	2.34B	134.00M	6.07%
Dec 31, 2019	2.21B	137.00M	6.62%
Dec 31, 2018	2.07B	134.00M	6.92%
Dec 31, 2017	1.94B	-14.00M	-0.72%
Dec 31, 2016	1.95B	510.00M	35.42%
Dec 31, 2015	1.44B	-49.00M	-3.29%
Dec 31, 2014	1.49B	124.00M	9.08%
Dec 31, 2013	1.37B	256.00M	23.08%
Dec 31, 2012	1.11B	190.98M	20.80%
Dec 31, 2011	918.03M	187.09M	25.60%
Dec 31, 2010	730.94M	94.05M	14.77%
Dec 31, 2009	636.88M	56.23M	9.68%
Dec 31, 2008	580.66M	131.86M	29.38%
Dec 31, 2007	448.80M	131.77M	41.57%
Dec 31, 2006	317.02M	54.81M	20.90%
Dec 31, 2005	262.22M	-	-

Data Source: Fiscal.ai Last updated: Aug 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 22, 2026

Data Sources Report a data error